- TheStreet.com•28 minutes ago
The company decreased its 13% stake in Mylan Friday.
- Zacks•50 minutes ago
Pfizer, Inc. (PFE) and German partner Merck KGaA's investigational cancer treatment, avelumab, was approved by the FDA for the treatment of metastatic Merkel cell carcinoma (MCC), a rare and aggressive form of skin cancer.
PFE : Summary for Pfizer, Inc. - Yahoo Finance
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Bid||34.21 x 1000|
|Ask||34.49 x 400|
|Day's Range||34.05 - 34.27|
|52 Week Range||29.41 - 37.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||29.05|
|Dividend & Yield||1.28 (3.71%)|
|1y Target Est||N/A|